Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours ยท Estimated delivery Aug 22 - Aug 27
The market is projected to grow at a CAGR of 10.04% over the forecast period from 2026 to 2035
Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not take these medications
For in-vitro laboratory handling only
Januvia (sitagliptin) is a DPP4 inhibitor approved to help control blood sugar in adults with type 2 diabetes when combined with diet and exercise
We have now explored the role of the classical GLP-1 receptor further by extending our studies to Glp1r knockout mice (9)
US$ 20.49
US$ 20.14
US$ 20.42
US$ 23.65
